An exploratory study of administration of Etanercept for patients with idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell trasnplantatio
Not Applicable
- Conditions
- idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000017738
- Lead Sponsor
- nivesity of Tokyo Hospital, Department of Hematology and Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients without enough . (2) the presence of any of the following after at the time of enrollment. (a) an active pulmonary infection as determined by positive culture of bronchoalveolar lavage (BAL) fluid. (b) hypotension in which inotropic support other than dopamine was required. (c) bacteremia within 48 hours before study entry. (d) CMV viremia. (e) systemic fungal or other nonbacterial infections. (f) clinical or echocardiographic evidence for cardiac dysfunction as the cause of respiratory failure. (3) pregnancy or lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method